UCB SA (UCB) – Medical Equipment – Deals and Alliances Profile by HTF

 

HTF Market Intelligence released a new research report of 31 pages on title ‘UCB SA (UCB) – Medical Equipment – Deals and Alliances Profile’  with detailed analysis, forecast and strategies.

Summary

UCB SA (UCB) is a biopharmaceutical company that discovers and develops medicines and solutions to help treat various diseases. It focuses mainly on products for the treatment of central nervous system (CNS) and immunology related conditions. The core products of the company include Vimpat (lacosamide), Neupro (rotigotine), Metadate CD (methylphenidate HCl), Cimzia (certolizumab pegol), Xyzal (levocetirizine), Zyrtec (cetirizine, including Zyrtec-Desv/Cirrus), and Tussione x (hydrocodone polistirex and chlorpheniramine polistirex). The company is also developing new therapies with focus on focus on neurology and immunology diseases. UCB operates subsidiaries in the US, Japan, China, Germany, Italy, Spain, France, the UK, Ireland, Belgium, Brazil, Russia, India, Mexico, Turkey and other countries. UCB is headquartered in Brussels, Belgium.

 

UCB SA (UCB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

 

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

 

Scope

 

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

– Business Description – A brief description of the company’s operations.

– Key Employees – A list of the key executives of the company.

– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.

– Key Competitors – A list of the key competitors of the company.

– Key Recent Developments – A brief on recent news about the company.

 

Reasons to Buy

 

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements

– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

 

Understand the company’s business segments’ expansion / divestiture strategy

– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

 

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company

– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

 

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

 

Stay up-to-date on the major developments affecting the company

– Recent developments concerning the company presented in the profile help you track important events.

 

Gain key insights into the company for academic or business research

– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

 

Note*: Some sections may be missing if data is unavailable for the company.

 

 

Companies Mentioned in Report

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/374321-ucb-sa-ucb-medical-equipment-deals-and-alliances-profile

 

Table of Contents 

Table of Contents  2

List of Tables  3

List of Figures  4

UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017  5

UCB SA, Medical Equipment Deals By Type, 2011 to YTD 2017  6

UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017  7

UCB SA, Medical Equipment, Deals By Market, 2011 to YTD 2017  8

UCB SA, Medical Equipment, Deals Summary, 2011 to YTD 2017  9

UCB SA, Medical Equipment, Deal Details  10

Partnerships  10

MC10 Enters into Agreement with UCB  10

Evogen Enters into Agreement with UCB  10

MC10 Enters into Co-Development Agreement with UCB  11

Allium Medical Solutions Enters Into Distribution Agreement With Meizler UCB Biopharma For Urological Stents  11

OTR3 Enters Into Distribution Agreement With UCB For Cacipliq20  12

Acquisition  13

UCB Acquires 51% Stake In Meizler Biopharma  13

UCB SA – Key Competitors  15

Key Employees  16

Locations And Subsidiaries  18

Head Office  18

Other Locations & Subsidiaries  18

Recent Developments  22

Strategy And Business Planning  22

Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery  22

Financial Announcements  23

Jul 27, 2016: UCB continues to deliver on its growth strategy  23

Apr 25, 2016: UCB First Three Months Interim Report 2016  24

Feb 26, 2016: UCB with progress on its growth path delivering value to patients and shareholders  25

Corporate Communications  27

Mar 24, 2017: UCB General Meeting on 27 April 2017  27

Dec 15, 2016: New appointments on UCB’s Board of Directors  28

Mar 25, 2016: Nominations for new members of UCB’s Board of Directors  29

Jan 15, 2016: UCB’s Executive Committee welcomes a new member  30

Appendix  31

Methodology  31

About GlobalData  31

Contact Us  31

Disclaimer  31List of Tables

UCB SA, Medical Equipment, Key Facts, 2016  1

UCB SA, Medical Equipment, Deals Summary, 2011 to YTD 2017  1

UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017  5

UCB SA, Medical Equipment Deals By Type, 2011 to YTD 2017  6

UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017  7

UCB SA, Deals By Market, 2011 to YTD 2017  8

UCB SA, Medical Equipment, Deals Summary, 2011 to YTD 2017  9

MC10 Enters into Agreement with UCB  10

Evogen Enters into Agreement with UCB  10

MC10 Enters into Co-Development Agreement with UCB  11

Allium Medical Solutions Enters Into Distribution Agreement With Meizler UCB Biopharma For Urological Stents  11

OTR3 Enters Into Distribution Agreement With UCB For Cacipliq20  12

UCB Acquires 51% Stake In Meizler Biopharma  13

UCB SA, Key Competitors  15

UCB SA, Key Employees  16

UCB SA, Subsidiaries  18List of Figures

UCB SA, Medical Equipment, Deals by Type, 2011 to YTD 2017  1

UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017  1

UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017  1

UCB SA, Medical Equipment, Deals By Market, 2011 to YTD 2017  1

UCB SA, Medical Equipment, Deals By Year, 2011 to YTD 2017  5

UCB SA, Medical Equipment, Deals by Type, 2011 to YTD 2017  6

UCB SA, Medical Equipment, Deals By Region, 2011 to YTD 2017  7

UCB SA, Medical Equipment, Deals by Market, 2011 to YTD 2017  8

 

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=374321

 

Contact Us:

CRAIG FRANCIS (PR & Marketing Manager)

sales@htfmarketreport.com

Ph: +1 (206) 317 1218

Designed by CyFocus.com
Powered by CyFocus.net